chronic obstructive pulmonary disease

MINNEAPOLIS, Minnesota, July 1, 2026 Nuvaira, Inc. has announced the first patient treated in the pivotal AIRFLOW-4 clinical trial...

TURIN, Italy | June 19, 2026 Kither Biotech has announced the successful completion of its first-in-human Phase 1 clinical...

BOSTON, June 15, 2026 Bambusa Therapeutics has announced positive preliminary results from the multiple ascending dose (MAD) cohorts of...

CHENGDU, China – June 9, 2026 Kelun-Biotech has announced that its partner Windward Bio has successfully dosed the first...

WASHINGTON, D.C., June 5, 2026 Altesa BioSciences has unveiled encouraging new Phase 2 clinical findings demonstrating that vapendavir, its...